Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 3776 - 3800 of 6046 in total
Sub Class LM ID Name ▼ LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Simple Glc series LMSP05010041
  • Dracontioside B
  • N-(2R-hydroxytetracosanoyl)-1-beta-glucosyl-4R-hydroxy-8Z-octadecasphingenine
9832502 843.679949 C48H93NO10
Simple Glc series LMSP05010040
  • Dracontioside A
  • N-(2R-hydroxyoctadecanoyl)-1-beta-glucosyl-4E,8Z-octadecasphingadienine
134812535 741.575484 C42H79NO9
LMSL02000002
  • Dodecanoyl-Kdo2-Lipid IVA
  • Lauroyl-Kdo2-Lipid IVA
9776848 2027.137644 C96H176N2O38P2
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR08
  • Cytolipin R(d18:1/26:1(17Z))
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261579 1364.890793 C70H128N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR06
  • Cytolipin R(d18:1/26:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261577 1366.906443 C70H130N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR07
  • Cytolipin R(d18:1/24:1(15Z))
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261578 1336.859493 C68H124N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR05
  • Cytolipin R(d18:1/24:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261576 1338.875143 C68H126N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR04
  • Cytolipin R(d18:1/22:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261575 1310.843843 C66H122N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR03
  • Cytolipin R(d18:1/20:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261574 1282.812543 C64H118N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR02
  • Cytolipin R(d18:1/18:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261573 1254.781243 C62H114N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR01
  • Cytolipin R(d18:1/16:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261572 1226.749943 C60H110N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR00
  • Cytolipin R
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer
GSG1155
Simple Glc series LMSP05010129
  • Crispin B
  • N-(2R-hydroxy-7Z-pentadecenoyl)-(6-O-(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl)-1-alpha-glucosyl-4E-nonadecasphingenine
171119969 903.607179 C51H85NO12
Simple Glc series LMSP05010128
  • Crispin A
  • N-(2R-hydroxy-7Z-pentadecenoyl)-1-alpha-glucosyl-4E-nonadecasphingenine
171119968 713.544184 C40H75NO9
Simple Glc series LMSP05010109
  • Cortenuamide C
  • N-(2R-hydroxy-docosanoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E-dienine
45272231 811.653734 C47H89NO9
Simple Glc series LMSP05010110
  • Cortenuamide B
  • N-(2R-hydroxy-tricosanoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E-dienine
171119946 825.669384 C48H91NO9
Simple Glc series LMSP05010111
  • Cortenuamide A
  • N-(2R-hydroxy-tetracosanoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E-dienine
171119945 839.685034 C49H93NO9
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG08
  • ClcNAc-Lex-5(d18:1/26:1(17Z))
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261443 1714.028077 C84H151N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG06
  • ClcNAc-Lex-5(d18:1/26:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261441 1716.043727 C84H153N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG07
  • ClcNAc-Lex-5(d18:1/24:1(15Z))
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261442 1685.996777 C82H147N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG05
  • ClcNAc-Lex-5(d18:1/24:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261440 1688.012427 C82H149N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG04
  • ClcNAc-Lex-5(d18:1/22:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261439 1659.981127 C80H145N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG03
  • ClcNAc-Lex-5(d18:1/20:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261438 1631.949827 C78H141N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG02
  • ClcNAc-Lex-5(d18:1/18:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261437 1603.918527 C76H137N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG01
  • ClcNAc-Lex-5(d18:1/16:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261436 1575.887227 C74H133N3O32

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024